Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-062818

President, R&D sold 980 shares at $14.49 ($14,200)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-12-27 Sale −980 $14.49 $14,200 85,886 D
Open-market sales · 980 sh · avg $14.49 · $14,200
Loading xslF345X03/doc4.xml…